{"id":"https://openalex.org/W2432979177","doi":null,"title":"A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.","display_name":"A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.","alternate_titles":[],"publication_year":1994,"publication_date":"1994-04-01","ids":{"openalex":"https://openalex.org/W2432979177","mag":"2432979177","pmid":"https://pubmed.ncbi.nlm.nih.gov/7548638"},"language":"en","primary_location":{"id":"pmid:7548638","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7548638","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design and discovery","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2432979177"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010969122","display_name":"Wilma Kuipers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"W Kuipers","raw_affiliation_strings":["Solvay Duphar B.V., Department of Medicinal Chemistry, Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Duphar B.V., Department of Medicinal Chemistry, Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":null,"display_name":"I Van Wijngaarden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Van Wijngaarden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065525958","display_name":"Adriaan P. IJzerman","orcid":"https://orcid.org/0000-0002-1182-2259","observed_orcids":["https://orcid.org/0000-0002-1182-2259"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A P Ijzerman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6806,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.62094834,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"11","issue":"3","first_page":"231","last_page":"249"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.972000002861023},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7089999914169312},{"id":"https://openalex.org/keywords/agonist-binding-site","display_name":"agonist binding site","score":0.7080000042915344},{"id":"https://openalex.org/keywords/antagonist-binding-site","display_name":"antagonist binding site","score":0.9819999933242798},{"id":"https://openalex.org/keywords/site-directed-mutagenesis","display_name":"site-directed mutagenesis","score":0.8399999737739563},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8510000109672546},{"id":"https://openalex.org/keywords/8-oh-dpat","display_name":"8-OH-DPAT","score":0.8199999928474426},{"id":"https://openalex.org/keywords/aryloxypropanolamines","display_name":"aryloxypropanolamines","score":0.8859999775886536},{"id":"https://openalex.org/keywords/ligand-receptor-interactions","display_name":"ligand-receptor interactions","score":0.718999981880188},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8101581931114197},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6929042339324951},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6586911082267761},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.6340292096138},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6126779317855835},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5416889190673828},{"id":"https://openalex.org/C2781093953","wikidata":"https://www.wikidata.org/wiki/Q21115043","display_name":"5-HT1A receptor","level":5,"score":0.5145018100738525},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.5108156204223633},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.5011067390441895},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.43268460035324097},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.41822534799575806},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.4159674346446991},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.40770435333251953},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.36714863777160645},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001436","descriptor_name":"Bacteriorhodopsins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002627","descriptor_name":"Chemistry, Physical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008956","descriptor_name":"Models, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016297","descriptor_name":"Mutagenesis, Site-Directed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019204","descriptor_name":"GTP-Binding Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D055598","descriptor_name":"Chemical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:7548638","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7548638","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design and discovery","raw_type":"Journal Article"},{"id":"mag:2432979177","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7548638","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1980881457","https://openalex.org/W1996191954","https://openalex.org/W2038245701","https://openalex.org/W2162407706","https://openalex.org/W2021663918","https://openalex.org/W2016100486","https://openalex.org/W2114650590","https://openalex.org/W2022061224","https://openalex.org/W4390265017","https://openalex.org/W2313657074"],"abstract_inverted_index":{"We":[0],"built":[1],"a":[2,14],"model":[3,103],"for":[4,67,73,94,136,147,156],"the":[5,9,18,41,46,49,68,90,95,104,107,120,143,148,151,157],"5-HT1A":[6,26,62,96],"receptor,":[7],"using":[8],"3D-structure":[10],"of":[11,20,48,61,81,92,142,150,153,160,163],"bacteriorhodopsin":[12],"as":[13],"structural":[15,32],"template.":[16],"With":[17],"use":[19],"site-directed":[21],"mutagenesis":[22],"data,":[23],"several":[24,114],"potent":[25],"agonists,":[27],"belonging":[28],"to":[29,52,130,134,167],"five":[30],"different":[31,111],"classes,":[33],"and":[34,85,106,155],"an":[35,71],"aryloxypropanolamine":[36],"antagonist,":[37],"were":[38],"docked":[39],"into":[40],"receptor":[42,97],"model.":[43],"After":[44],"docking,":[45],"surrounding":[47],"ligands":[50,84],"appeared":[51],"be":[53],"in":[54,79],"full":[55],"agreement":[56],"with":[57,110,119],"previously":[58],"reported":[59],"SAR-data":[60],"ligands.":[63],"In":[64,101],"this":[65,161],"study,":[66],"first":[69],"time,":[70],"explanation":[72],"5-HT":[74],"SAR":[75,159],"results":[76],"is":[77,98,128],"given":[78],"terms":[80],"interactions":[82],"between":[83],"amino":[86],"acid":[87,123],"residues.":[88],"Also":[89],"selectivity":[91],"8-OH-DPAT":[93],"accounted":[99],"for.":[100],"our":[102],"agonists":[105],"antagonist":[108],"interact":[109,118],"residues":[112],"on":[113,124],"helices.":[115],"They":[116],"all":[117,132],"essential":[121],"aspartic":[122],"helix":[125],"III,":[126],"that":[127],"known":[129],"bind":[131],"amines":[133],"receptors":[135],"biogenic":[137],"amines.":[138],"This":[139],"partial":[140],"overlap":[141],"binding":[144],"sites":[145],"accounts":[146],"antagonism":[149],"class":[152,162],"aryloxypropanolamines":[154],"deviating":[158],"compounds":[164],"when":[165],"compared":[166],"agonists.":[168]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2432979177","counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
